If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Atsushi Osoegawa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
CD274 Antigen Medicine & Life Sciences
Indoleamine-Pyrrole 2,3,-Dioxygenase Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 527 Citations
  • 12 h-Index
  • 51 Article
  • 2 Review article
1 Citation (Scopus)

A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma

Matsubara, T., Takada, K., Azuma, K., Takamori, S., Toyokawa, G., Haro, A., Osoegawa, A., Tagawa, T., Kawahara, A., Akiba, J., Okamoto, I., Nakanishi, Y., Oda, Y., Hoshino, T. & Maehara, Y., Jun 15 2019, In : Annals of Surgical Oncology. 26, 6, p. 1925-1933 9 p.

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Ligands
Lung
CD274 Antigen
Immunotherapy

Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma

Takada, K., Shimokawa, M., Tanaka, K., Kouhashi, K., Haro, A., Osoegawa, A., Tagawa, T., Azuma, K., Okamoto, I., Oda, Y. & Mori, M., Jun 1 2019, In : PloS one. 14, 6, e0217991.

Research output: Contribution to journalArticle

Open Access
Indoleamine-Pyrrole 2,3,-Dioxygenase
Immunologic Factors
adenocarcinoma
Cell death
Tumors

Association of Low Body Mass Index with Poor Clinical Outcomes after Resection of Non-small Cell Lung Cancer

Takada, K., Shimokawa, M., Akamine, T., Ono, Y., Haro, A., Osoegawa, A., Tagawa, T. & Mori, M., Apr 1 2019, In : Anticancer research. 39, 4, p. 1987-1996 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Body Mass Index
Disease-Free Survival
Survival
CD274 Antigen

Clinical and Prognostic Significance of the Epithelial–Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score–Matched Analysis

Matsubara, T., Tagawa, T., Takada, K., Toyokawa, G., Shimokawa, M., Kozuma, Y., Akamine, T., Haro, A., Osoegawa, A. & Mori, M., Jan 1 2019, In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Propensity Score
Vimentin
Cadherins
Neoplasms
Disease-Free Survival
2 Citations (Scopus)

Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy

Takada, K., Kouhashi, K., Shimokawa, M., Haro, A., Osoegawa, A., Tagawa, T., Seto, T., Oda, Y. & Maehara, Y., Feb 1 2019, In : Lung Cancer. 128, p. 26-32 7 p.

Research output: Contribution to journalArticle

CD274 Antigen
Indoleamine-Pyrrole 2,3,-Dioxygenase
Squamous Cell Carcinoma
Lung
Therapeutics